← Back to Clinical Trials
Recruiting NCT06596993

NCT06596993 Developing a Balance Rehabilitation System for Older Adults, Based on IMU and AI: Personalized Training and Preventive Strategies

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06596993
Status Recruiting
Phase —
Sponsor National Taiwan University Hospital
Condition Community-dwelling Older Adults
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2023-11-03
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
IMU-based balance traininggeneral health education or exercise training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2023-11-03 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aging physiological state of the elderly may lead to problems such as unstable gait, balance disorders, and falls. Previous research has confirmed that exercise training can help improve the physical function, quality of life, and reduce the risk of falls in the elderly. In order to achieve effective and continuous intervention training, somatosensory games have become a trend in recent years. Among them, the use of non-immersive virtual reality training methods not only provides training for the elderly, but also reduces the discomfort caused by the virtual environment; however, there are some limitations in clinical rehabilitation training methods, such as the lack of data-based evaluation and personalization. In order to solve the above problems, this research plan will use the inertial measurement unit as a tool for clinical monitoring and human movement assessment, and use artificial intelligence technology to evaluate and adjust the training plan according to its gait characteristics to achieve personalization Training and prevention strategies.

Eligibility Criteria

Inclusion Criteria: Aged between 18 and 80 years capable of independent walking- Exclusion Criteria: 1. history of lower limb orthopedic surgery, ankylosing spondylitis, rheumatoid arthritis, osteoarthritis, and other medical joint diseases 2. Those who cannot communicate or follow instructions, and those with severe visual or hearing impairments 3. the neurological impairment or vestibular disorders, such as stroke, spinal cord injury, Meniere's syndrome.

Contact & Investigator

Central Contact

Hsu Wei-Li, Ph. D

✉ wlhsu@ntu.edu.tw

📞 886-2-33668127

Frequently Asked Questions

Who can join the NCT06596993 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Community-dwelling Older Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06596993 currently recruiting?

Yes, NCT06596993 is actively recruiting participants. Contact the research team at wlhsu@ntu.edu.tw for enrollment information.

Where is the NCT06596993 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT06596993 clinical trial?

NCT06596993 is sponsored by National Taiwan University Hospital. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology